Advanced search
Publication Cover
Expert Opinion on Emerging Drugs Volume 24, 2019 - Issue 1
Submit an article Journal homepage
441
Views
8
CrossRef citations to date
0
Altmetric
Review

Standard treatment and emerging drugs for managing synovial sarcoma: adult’s and pediatric oncologist perspective

Giacomo G. Baldi“Sandro Pitigliani” Medical Oncology Department, Hospital of Prato, Prato, ItalyCorrespondence[email protected]
View further author information
,
Daniel OrbachSIREDO Oncology Center, PSL University, Institut Curie, Paris, FranceView further author information
,
Rossella BertulliMedical Oncology Unit 2, Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, ItalyView further author information
,
Chiara MagniPediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, ItalyView further author information
,
Giovanna SironiPediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, ItalyView further author information
,
Michela CasanovaPediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, ItalyView further author information
&
Andrea FerrariPediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, ItalyView further author information
 show all
Pages 43-53 | Received 04 Nov 2018, Accepted 04 Mar 2019, Published online: 02 Apr 2019

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Andrea Ferrari, Bernadette Brennan, Michela Casanova, Nadege Corradini, Pablo Berlanga, Reineke A Schoot, Gema L Ramirez-Villar, Akmal Safwat, Gabriela Guillen Burrieza, Patrizia Dall’Igna, Rita Alaggio, Lisa Lyngsie Hjalgrim, Susanne Andrea Gatz, Daniel Orbach & Max M van Noesel. (2022) Pediatric Non-Rhabdomyosarcoma Soft Tissue Sarcomas: Standard of Care and Treatment Recommendations from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG). Cancer Management and Research 14, pages 2885-2902.
Read now
Yitian Wang, Minxun Lu, Yong Zhou, Sisi Zhou, Xinzhu Yu, Fan Tang, Yi Luo, Wenli Zhang, Hong Duan, Li Min & Chongqi Tu. (2020) The Efficacy and Safety of Apatinib in Advanced Synovial Sarcoma: A Case Series of Twenty-One Patients in One Single Institution. Cancer Management and Research 12, pages 5255-5264.
Read now

Articles from other publishers (6)

Cinzia Lanzi & Giuliana Cassinelli. (2022) Combinatorial strategies to potentiate the efficacy of HDAC inhibitors in fusion-positive sarcomas. Biochemical Pharmacology 198, pages 114944.
Crossref
Andrea Ferrari & Rita Alaggio. 2022. Rare Tumors in Children and Adolescents. Rare Tumors in Children and Adolescents 535 582 .
Cinzia Lanzi, Enrica Favini, Laura Dal Bo, Monica Tortoreto, Noemi Arrighetti, Nadia Zaffaroni & Giuliana Cassinelli. (2021) Upregulation of ERK-EGR1-heparanase axis by HDAC inhibitors provides targets for rational therapeutic intervention in synovial sarcoma. Journal of Experimental & Clinical Cancer Research 40:1.
Crossref
E. Rossetti, G. Gonzalez Diaz, J. Lopez Marti, S. Innocenti, W. Cacciavillano, G. Felizzia, M. Viso, M.L. Ramos, P. Zubizarreta & A. Rose. (2021) Synovial sarcoma in children: A 15-YEAR experience at a tertiary pediatric center in Argentina. Pediatric Hematology Oncology Journal 6:4, pages 175-185.
Crossref
Monika Scheer, Christian Vokuhl, Sebastian Bauer, Jörg Fuchs, Steffan Loff, Beate Timmermann, Marc Münter, Anton George Henssen, Bernarda Kazanowska, Felix Niggli, Ruth Ladenstein, Gustaf Ljungman, Ewa Koscielniak & Thomas Klingebiel. (2021) The effect of adjuvant therapies on long-term outcome for primary resected synovial sarcoma in a series of mainly children and adolescents. Journal of Cancer Research and Clinical Oncology 147:12, pages 3735-3747.
Crossref
Ryland Hale, Sami Sandakly, Janet Shipley & Zoë Walters. (2019) Epigenetic Targets in Synovial Sarcoma: A Mini-Review. Frontiers in Oncology 9.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.